Efficacy and safety of nemolizumab and topical corticosteroids for prurigo nodularis: results from a randomized double-blind placebo-controlled phase II/III clinical study in patients aged ≥ 13 yearsHiroo Yokozeki, Haruko Nishie, Masatoshi Abe et al.|British Journal of Dermatology|2024Cited by 18
Clinical Characteristics and Risk Factors for Cutaneous Manifestations Associated With Nemolizumab in Atopic Dermatitis: A Multicenter Retrospective Study in JapanWataru Sasaki, Mariko Sugawara‐Mikami, Ryo� Saito et al.|The Journal of Dermatology|2025Cited by 8